Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis

International Immunopharmacology

Volumn 15, Issue 2, 2013, Pages 372-380

  Martínez Moya, Patricia ^a   Romero Calvo, Isabel ^a   Requena, Pilar ^a   Hernández Chirlaque, Cristina ^a   Aranda, Carlos J ^a   González, Raquel ^a   Zarzuelo, Antonio ^a   Suárez, María Dolores ^a   Martínez Augustin, Olga ^a   Marín, José Juan G ^b   De Medina, Fermín Sánchez ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Bile acid; Budesonide; Inflammatory bowel disease

Indexed keywords

ALKALINE PHOSPHATASE; TRINITROBENZENESULFONIC ACID; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPY EFFECT;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTESTINAL MUCOSA; RATS; RATS, WISTAR; TRINITROBENZENESULFONIC ACID; URSODEOXYCHOLIC ACID;

EID: 84873019964     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.11.017     Document Type: Article

References (25)

1. O. Martinez-Augustin, I. Romero-Calvo, M.D. Suarez, A. Zarzuelo, and F. Sanchez de Medina Molecular bases of impaired water and ion movements in inflammatory bowel diseases Inflamm Bowel Dis 15 2009 114 127
2. A.M. O'Hara, and F. Shanahan The gut flora as a forgotten organ EMBO Rep 7 2006 688 693
3. J.M. Ridlon, D.J. Kang, and P.B. Hylemon Bile salt biotransformations by human intestinal bacteria J Lipid Res 47 2006 241 259
4. A. Kaser, S. Zeissig, and R.S. Blumberg Inflammatory bowel disease Annu Rev Immunol 28 2010 573 621
5. O. Martínez-Augustin, and F. Sánchez de Medina Intestinal bile acid physiology and pathophysiology World J Gastroenterol 14 2008 5630 5640
6. C.F. Bernardes-Silva, A.O. Damiao, A.M. Sipahi, F.R. Laurindo, K. Iriya, and F.P. Lopasso Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress Dig Dis Sci 49 2004 1569 1574
7. F. Kullmann, V. Gross, J. Ruschoff, H. Arndt, W. Benda, and A. Winkler von Mohrenfels Effect of ursodeoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats Z Gastroenterol 35 1997 171 178
8. J.D. Lloyd-Still, D.W. Beno, M.R. Uhing, V.A. Jiyamapa-Serna, and R.E. Kimura Ursodeoxycholic acid ameliorates ibuprofen-induced enteropathy in the rat J Pediatr Gastroenterol Nutr 32 2001 270 273
9. F. Kullmann, H. Arndt, V. Gross, J. Ruschoff, and J. Scholmerich Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis Eur J Gastroenterol Hepatol 9 1997 1205 1211
10. A. Uchida, T. Yamada, T. Hayakawa, and M. Hoshino Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation Am J Physiol 272 1997 G1249 G1257
11. O. Martínez-Augustin, R. López-Posadas, R. González, M.D. Suárez, A. Zarzuelo, and F. Sánchez de Medina Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with modulation of NF-kB but not PPAR-g signaling Pharmacogenet Genomics 19 2009 363 372
12. M.J. Palmen, L.A. Dieleman, M.B. van der Ende, A. Uyterlinde, A.S. Pena, and S.G. Meuwissen Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis Clin Exp Immunol 99 1995 226 232
13. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350
14. R. Lopez-Posadas, R. Gonzalez, I. Ballester, P. Martinez-Moya, I. Romero-Calvo, and M.D. Suarez Tissue-nonspecific alkaline phosphatase is activated in enterocytes by oxidative stress via changes in glycosylation Inflamm Bowel Dis 17 2011 543 556
15. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, and M.D. Provenzano Measurement of protein using bicinchoninic acid Anal Biochem 150 1985 76 85
16. A. Gutierrez, R. Frances, A. Amoros, P. Zapater, M. Garmendia, and M. Ndongo Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease Inflamm Bowel Dis 15 2009 508 514
17. K.A. Sharkey, and J.L. Wallace Treatment of disorders of bowel motility and water flux; antiemetics; agents used in biliary and pancreatic disease L.L. Brunton, Goodman and Gilman's the pharmacological basis of therapeutics 12th edition 2011 McGraw-Hill China 1323 1350
18. T. Shea-Donohue, K. Thomas, M.J. Cody, Z. Aiping, L.J. Detolla, and K.M. Kopydlowski Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis Innate Immun 14 2008 117 124
19. J.C. Hoffmann, N.N. Pawlowski, K. Grollich, C. Loddenkemper, M. Zeitz, and A.A. Kuhl Gammadelta T lymphocytes: a new type of regulatory T cells suppressing murine 2,4,6-trinitrobenzene sulphonic acid (TNBS)-induced colitis Int J Colorectal Dis 23 2008 909 920
20. S.K. Sainathan, E.M. Hanna, Q. Gong, K.S. Bishnupuri, Q. Luo, and M. Colonna Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis Inflamm Bowel Dis 14 2008 88 99
21. D.K. Lee, S.Y. Park, S.K. Baik, S.O. Kwon, J.M. Chung, and E.S. Oh Deoxycholic acid-induced signal transduction in HT-29 cells: role of NF-kappa B and interleukin-8 Korean J Gastroenterol 43 2004 176 185
22. M. Muhlbauer, B. Allard, A.K. Bosserhoff, S. Kiessling, H. Herfarth, and G. Rogler Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells Am J Physiol Gastrointest Liver Physiol 286 2004 G1000 G1008
23. C.M. Rodrigues, B.T. Kren, C.J. Steer, and K.D. Setchell Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate Gastroenterology 109 1995 564 572
24. M.H. Floch, H.J. Binder, B. Filburn, and W. Gershengoren The effect of bile acids on intestinal microflora Am J Clin Nutr 25 1972 1418 1426
25. E.A. Deitch, K. Sittig, M. Li, R. Berg, and R.D. Specian Obstructive jaundice promotes bacterial translocation from the gut Am J Surg 159 1990 79 84